Aurobindo Pharma Shares Down More Than 6% Amid US FDA Inspection menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Aurobindo Pharma shares fell more than 6 per cent on Thursday amid an inspection by the US Food and Drug Administration (FDA).Aurobindo Pharma shares were down 6.6 per cent at Rs 1,074 on the BSE. The company has a market cap of Rs 62,950 .
Aurobindo Pharma shares down more than 6% amid US FDA inspection smetimes.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smetimes.in Daily Mail and Mail on Sunday newspapers.
The J&K Bank QIP opened on December 11, with the J&K Bank approving the floor price of the QIP at Rs 112.66 per share. The lender said it would, at its discretion, offer a discount of not more than 5 per cent on the floor price.
BOI QIP kicked off on Tuesday, with the public sector lender approving the floor price at Rs 105.42 per equity share based on the pricing formula as prescribed under Regulation 176 of the SEBI ICDR Regulation.